OHIO: New HIV/AIDS Cases Down Among Those Who Use Needles

Important note: Information in this article was accurate in 2005. The state of the art may have changed since the publication date.

OHIO: New HIV/AIDS Cases Down Among Those Who Use Needles

Plain Dealer (Cleveland) (12.01.05) - Thursday, December 08, 2005
Regina McEnery

With the help of the public-private AIDS Funding Collaborative, the Free Clinic of Greater Cleveland (FCGC) operates Ohio's only sanctioned grassroots needle exchange program (NEP). Working discreetly from a van at long-standing locations on Cedar Avenue and West 25th Street, the program dispenses clean syringes, water, bleach and counseling to help prevent blood-borne infections among injection drug users (IDUs).

Between 2001 and 2004, HIV diagnoses among IDUs decreased in the United States, according to a recent CDC study covering 33 states. Nearly every US state has at least one NEP, though researchers did not establish a link between specific NEPs and the decline. Nonetheless, supporters of Cleveland's NEP believe it prevents new HIV infections.

In 1995, Cleveland Mayor Michael White declared an AIDS emergency, allowing the operation of NEPs. Despite intermittent increases, the 10-year-old Cuyahoga County program has seen the rate of new HIV/AIDS cases associated with drug injection drop from 12.8 percent in 1995 to 7.8 percent in 2005. In routine testing of clients for STDs and HIV, the program recorded one HIV infection this year. Last year, there were none.

The NEP's clientele includes white-collar professionals, sex workers, the homeless and the working poor, said Gail Bromley, FCGC's executive director. It exchanges about 120,000 needles annually, has approximately 950 registered clients, and serves some 120 regular clients a month. The goal of the confidential program, said Bromley, is to channel as many clients into detoxification as possible.
051208
AD052478

Copyright © 2005 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.